Evaluation of carnitine deficit in very low birth weight preterm newborns small for their gestational age

References

• Brodsky D, Christou H. Current concepts in intrauterine growth restriction. J Intensive Care Med 2004;19:307–19
   PubMedGoogle Scholar
• Negrato CA, Gomes MB. Low birth weight: causes and consequences. Diabetol Metabol Syndr 2013;5:49–57
   PubMed Web of Science ®Google Scholar
• Jansson T, Powell TL. Placental nutrient transfer and fetal growth. Nutrition 2000;16:500–2
   PubMed Web of Science ®Google Scholar
• Jansson T, Powell TL. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci 2007;113:1–13
   PubMed Web of Science ®Google Scholar
• Jansson T, Scholtbach V, Powell TL. Placental transport of leucine and lysine is reduced in intrauterine growth restriction. Pediatr Res 1998;44:532–7
   PubMed Web of Science ®Google Scholar
• Norberg S, Powell TL, Jansson T. Intrauterine growth restriction is associated with a reduced activity of placental taurine transporters. Pediatr Res 1998;44:233–8
   PubMed Web of Science ®Google Scholar
• Glazier JD, Cetin I, Perugino G, et al. Association between the activity of the system A amino acid transporter in the microvillous plasma membrane of the human placenta and severity of fetal compromise in intrauterine growth restriction. Pediatr Res 1997;42:514–19
   PubMed Web of Science ®Google Scholar
• Ryckman KK, Shchelochkov OA, Cook DE, et al. The influence of maternal disease on metabolites measured as part of newborn screening. J Matern Fetal Neonatal Med 2013;26:1380–3
   PubMed Web of Science ®Google Scholar
• Lahjouji K, Elimrani I, Lafond J, et al. L-carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2. Am J Physiol Cell Physiol 2004;287:C263–9
   PubMed Web of Science ®Google Scholar
• Grube M, Meyer H, Draber K, et al. Expression, localization, and function of the carnitine transporter OCTN2 (SLC22A5) in human placenta. Drug Metab Dispos 2005;33:31–7
   PubMed Web of Science ®Google Scholar
• Oey NA, van Vlies N, Wijburg RJA, et al. L-carnitine is synthesized in the human fetal-placental unit: potential roles in placental and fetal metabolism. Placenta 2006;27:841–6
   PubMed Web of Science ®Google Scholar
• Sabel KG, Olegard R, Mellander M, Hildingsson K. Interrelation between fatty acid oxidation and control of gluconeogenic substrates in small-for-gestational-age (SGA) infants with hypoglycemia and with normoglycemia. Acta Paediatr Scand 1982;71:53–61
   PubMed Web of Science ®Google Scholar
• Bonner C, DeBrie K, Hug G. Effects of parenteral L-carnitine supplementation on fat metabolism and nutrition in premature neonates. J Pediatr 1995;126:287–92
   PubMed Web of Science ®Google Scholar
• Crill CM, Christensen ML, Storm MC, Helms RA. Relative bioavailability of carnitine supplementation in premature neonates. J Parenter Enteral Nutr 2006;30:421–5
   PubMed Web of Science ®Google Scholar
• Whitfield J, Smith T, Sollohub H, et al. Clinical effects of L-carnitine supplementation on apnea and growth in very low birth weight infants. Pediatrics 2003;111:477–82
   PubMed Web of Science ®Google Scholar
• Pande S, Brion LP, Campbell DE, et al. Lack of effect of L-carnitine supplementation on weight gain in very preterm infants. J Perinatol 2005;25:470–7
   PubMedGoogle Scholar
• Jones LL, Mc Donald DA, Borum PR. Acylcarnitines: role in brain. Progr Lipid Res 2010;49:61–75
   PubMed Web of Science ®Google Scholar
• Tastekin A, Gepdiremen A, Ors R, et al. Protective effect of L-carnitine against bilirubin-induced neuronal cell death. Brain Dev 2006;28:436–9
   PubMed Web of Science ®Google Scholar
• Meyburg J, Schulze A, Kohlmueller D, et al. Acylcarnitine profiles of preterm infants over the first four weeks of life. Pediatr Res 2002;52:720–3
   PubMed Web of Science ®Google Scholar
• Mares-Perlman JA, Farrell PM, Gutcher GR. Changes in erythrocyte and plasma carnitine concentrations in preterm neonates. Am J Clin Nutr 1986;43:77–84
   PubMed Web of Science ®Google Scholar
• Cederblad G, Svenningsen N. Plasma carnitine and breast milk carnitine intake in premature infants. J Pediatr Gastroenterol Nutr 1986;5:616–21
   PubMed Web of Science ®Google Scholar
• Akisu M, Bekler Ç, Yalaz M, et al. Free carnitine concentrations in cord blood in preterm and full term infants with intrauterine growth retardation. Pediatr Int 2001;43:107–8
   PubMed Web of Science ®Google Scholar
• Ahn E-M, Cho S-Ch, Lee M, Cha Y-S. Serum carnitine, triglyceride and cholesterol profiles in Korean neonates. Br J Nutr 2007;98:373–9
   PubMed Web of Science ®Google Scholar
• Bene J, Komlósi K, Melegh BI, et al. Differences in circulating carnitine status of the preterm infants fed fortified human milk or preterm infant formula. J Pediatr Gastroenterol Nutr 2013;57:673–6
   PubMed Web of Science ®Google Scholar
• Mandour I, El Gayar D, Amin M, et al. Amino acid and acylcarnitine profile in premature neonates: a pilot study. Indian J Pediatr 2013;80:736–44
   PubMed Web of Science ®Google Scholar
• Cairns PA, Stalker DJ. Carnitine supplementation of parenterally fed neonates. Cochrane Database Syst Rev 2000;(4):CD000950
   PubMedGoogle Scholar
• Esteban N, Golapareddy VG, Singh D. Total parenteral nutrition and carnitine supplementation practices in premature neonates. A national survey. Pediatr Res 2001;49:398A
   Google Scholar
• Carrascosa A, Fernández A, Yeste D, et al. Spanish cross-sectional growth study 2008. Part I: weight and height values in newborns of 26–42 weeks of gestational age. An Pediatr (Barc) 2008;68:544–51
   PubMedGoogle Scholar
• Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990;13:321–4
   PubMed Web of Science ®Google Scholar
• Shenai JP, Borum PR. Tissue carnitine reserves of newborn infants. Pediatr Res 1984;18:679–82
   PubMed Web of Science ®Google Scholar